Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feiyu Luo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|February 5, 2025
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapyYoumei Xiao, Zhuoying He, Wanqiong Li, et al.
Cell Reports. Medicine|January 22, 2026
Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapyDanhong Chen, Ran Xu, Xiaoyun Ye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 23, 2025
An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapyMengfan Wang, Xiaoyun Ye, Wanqiong Li, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|February 5, 2025
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapyYoumei Xiao, Zhuoying He, Wanqiong Li, et al.
Cell Reports. Medicine|January 22, 2026
Design of a bispecific peptide-nanozyme conjugate for cancer immunotherapyDanhong Chen, Ran Xu, Xiaoyun Ye, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 23, 2025
An oral vaccine based on stable peptide-chitosan conjugate targeting DEC-205 for cancer immunotherapyMengfan Wang, Xiaoyun Ye, Wanqiong Li, et al.
Pageof 2